- Home
- IMCC vs BRTX Comparison
IMCC vs BRTX Comparison
Compare IMCC & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCC
- BRTX
- Stock Information
- Founded
- IMCC 1980
- BRTX 1997
- Country
- IMCC Israel
- BRTX United States
- Employees
- IMCC N/A
- BRTX N/A
- Industry
- IMCC Medicinal Chemicals and Botanical Products
- BRTX Managed Health Care
- Sector
- IMCC Health Care
- BRTX Health Care
- Exchange
- IMCC Nasdaq
- BRTX Nasdaq
- Market Cap
- IMCC 11.8M
- BRTX 12.5M
- IPO Year
- IMCC N/A
- BRTX N/A
- Fundamental
- Price
- IMCC $2.81
- BRTX $1.62
- Analyst Decision
- IMCC
- BRTX Strong Buy
- Analyst Count
- IMCC 0
- BRTX 1
- Target Price
- IMCC N/A
- BRTX $18.00
- AVG Volume (30 Days)
- IMCC 75.2K
- BRTX 89.7K
- Earning Date
- IMCC 08-13-2025
- BRTX 08-12-2025
- Dividend Yield
- IMCC N/A
- BRTX N/A
- EPS Growth
- IMCC N/A
- BRTX N/A
- EPS
- IMCC N/A
- BRTX N/A
- Revenue
- IMCC $37,894,737.00
- BRTX $391,000.00
- Revenue This Year
- IMCC $47.12
- BRTX $216.71
- Revenue Next Year
- IMCC $12.83
- BRTX $60.63
- P/E Ratio
- IMCC N/A
- BRTX N/A
- Revenue Growth
- IMCC 12.68
- BRTX 161.54
- 52 Week Low
- IMCC $1.29
- BRTX $1.21
- 52 Week High
- IMCC $7.12
- BRTX $2.55
- Technical
- Relative Strength Index (RSI)
- IMCC 46.59
- BRTX 48.45
- Support Level
- IMCC $2.90
- BRTX $1.43
- Resistance Level
- IMCC $3.21
- BRTX $1.75
- Average True Range (ATR)
- IMCC 0.34
- BRTX 0.12
- MACD
- IMCC -0.07
- BRTX 0.01
- Stochastic Oscillator
- IMCC 5.05
- BRTX 52.78
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.